These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2159265)

  • 21. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
    Li DX; Chen XB
    Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
    Furuse K; Fukuoka M; Asamoto H; Niitani H; Kimura I; Sakuma A; Yamaguchi Y
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
    Setoguchi J; Sawada M; Onodera H; Sigeta M; Nakai M; Nakano K; Kanatsuna T; Kondoh M; Hotta T; Hayashi H
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2399-403. PubMed ID: 2546504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adriamycin, cisplatin and etoposide combination chemotherapy in non-small cell lung cancer].
    Yamaji Y; Fujita J; Kamei M; Futami H; Hashimoto Y; Bungo M; Nakamura H; Hata Y; Shiotani T; Irino S
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):601-6. PubMed ID: 1849390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
    Fujita A; Sasaki H; Mori T; Nakajima S; Sekine K; Inoue Y; Honda R; Asakawa M; Suzuki A
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):51-5. PubMed ID: 1846283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination chemotherapy consisting of ifosfamide and vindesine for non-small cell lung cancer in the elderly].
    Takigawa N; Segawa Y; Kishino D; Fujiwara K; Ida M; Eguchi K
    Nihon Kokyuki Gakkai Zasshi; 2000 Apr; 38(4):273-7. PubMed ID: 10879029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Five-day continuous infusion of vindesine in the treatment of non-small cell lung cancer--clinical pharmacokinetics of vindesine].
    Saito Y; Mori K; Tominaga K; Yokoi K; Miyazawa N
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2129-32. PubMed ID: 1653559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
    Höfeler H; Höffken K; Niederle N; Schoetensack B; Wandl U; Kath R; Müller M; Schmidt CG
    Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1961-6. PubMed ID: 3024948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
    Kodani T; Ueoka H; Kiura K; Tabata M; Takigawa N; Segawa Y; Moritaka T; Hiraki S; Harada M; Tanimoto M
    Lung Cancer; 2002 Jun; 36(3):313-9. PubMed ID: 12009244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination chemotherapy of non-small cell lung cancer (NSCLC) with cisplatin (CDDP), carboquone (CQ) and prednisolone (PDN)(PPQ therapy)].
    Nakao I; Ohashi Y; Ito K; Yokoyama T; Nishi I; Kanko T; Saito T
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):217-20. PubMed ID: 2154159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of chemotherapy of unresectable non-small cell lung cancer].
    Hirabayashi M; Tanaka Y; Yoshida H; Nakagawa M; Kawakami K; Mishima M; Kuno K
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):55-60. PubMed ID: 1309632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study.
    Honda R; Fujita A; Inoue Y; Asakawa M; Suzuki A
    Cancer Chemother Pharmacol; 1990; 26(5):373-6. PubMed ID: 2170045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer.
    Nakanishi Y; Takayama K; Kawasaki M; Yatsunami J; Inutsuka S; Wakamatsu K; Tsuruta N; Hara N
    Am J Clin Oncol; 1997 Aug; 20(4):393-7. PubMed ID: 9256897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueda N; Fujii M; Machida K; Ueoka H; Kawahara S; Kozuka A; Kiura K; Moritaka T
    Acta Med Okayama; 1991 Oct; 45(5):357-61. PubMed ID: 1661559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
    Rosell R; Abad-Esteve A; Moreno I; Barnadas A; Carles J; Fernandez C; Ribelles N; Culubret M
    Cancer; 1990 Apr; 65(8):1692-9. PubMed ID: 2156597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
    Vansteenkiste J; Vandebroek J; Mariën S; Roex L; Bertrand P; Bockaert J; De Beukelaar T; Deman R; De Muynck P; Ulrichts H
    Lung Cancer; 1995 Dec; 13(3):295-303. PubMed ID: 8719069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
    Le Chevalier T; Brisgand D; Pujol JL; Douillard JY; Monnier A; Rivière A; Chomy P; Le Groumellec A; Ruffie P; Gottfried M; Gaspard MH; Chevreau C; Alberola V; Cigolari S; Besson F; Martinez A; Besenval M; Berthaud P; Tursz T
    Bull Cancer; 1996 May; 83(5):385-94. PubMed ID: 8680091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
    Shimizu E; Ogura T; Sone S; Nakayama T; Doi H; Takishita Y; Bando H; Kobayashi M; Kimura K; Sasaki H
    Oncology; 1993; 50(1):5-9. PubMed ID: 8380634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.